Drug Information

Drug General Information
Drug ID
D08FDI
Former ID
DNC005201
Drug Name
3-(2-Pyridin-2-yl-2H-tetrazol-5-yl)-benzonitrile
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527190]
Formula
C13H8N6
Canonical SMILES
C1=CC=NC(=C1)N2N=C(N=N2)C3=CC=CC(=C3)C#N
InChI
1S/C13H8N6/c14-9-10-4-3-5-11(8-10)13-16-18-19(17-13)12-6-1-2-7-15-12/h1-8H
InChIKey
GHRSDAGWCBAULR-UHFFFAOYSA-N
PubChem Compound ID
9813637
Target and Pathway
Target(s) Metabotropic glutamate receptor 5 Target Info Inhibitor [527190]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Long-term potentiation
Retrograde endocannabinoid signaling
Glutamatergic synapse
Huntington's disease
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Metabotropic glutamate receptor group III pathway
Metabotropic glutamate receptor group I pathway
Endogenous cannabinoid signaling
Reactome G alpha (q) signalling events
Class C/3 (Metabotropic glutamate/pheromone receptors)
WikiPathways Hypothetical Network for Drug Addiction
GPCRs, Class C Metabotropic glutamate, pheromone
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
References
Ref 527190J Med Chem. 2004 Sep 9;47(19):4645-8.Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.
Ref 527190J Med Chem. 2004 Sep 9;47(19):4645-8.Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.